Study is 'the ultimate test' of beta-amyloid hypothesis

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.

November 2, 2022   24/7 Helpline: 800.272.3900 Study is ‘the ultimate test’ of beta-amyloid hypothesis Researchers are launching the DIAN-TU Primary Prevention Trial, a study designed to test whether stopping the buildup of a sticky substance in the brain called beta-amyloid will prevent Alzheimer's disease. The trial, which is funded by the Alzheimer’s Association, the National Institute on Aging, GHR Foundation, Edward Jones and others, will give a treatment to people as young as 18 who have a rare gene mutation that causes Alzheimer’s. Honor an Alzheimer's disease caregiver In the United States, more than 11 million family members and friends are Alzheimer's and dementia caregivers. Join us as we honor them during National Alzheimer’s Disease Awareness Month and National Family Caregivers Month for their dedication, selflessness and strength in the fight against Alzheimer’s. Help fight Alzheimer's Give Now Get Involved Your Local Community Dallas and Northeast Texas   Round Pond Estate continues its support of the Alzheimer's Association Round Pond Estate is again joining the fight against Alzheimer's in November. Round Pond will honor the memory of the company's late founder, Bob MacDonnell, by donating 3% of sales from all wines to the Alzheimer's Association. Create a free, customized action plan with Alzheimer's Navigator.   More Resources:    Stages of Alzheimer's  |    Behaviors  |    Coping Strategies  |    Care Training

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Alzheimer's Association Home Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601 © 2022 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900.